Research Article

Related GMR Articles

08/29/2014
Genetic polymorphisms; Hepatocellular carcinoma; MDR1 gene; Risk factors; susceptibility

The objective of this study was to evaluate the influence of c.1564A>T genetic polymorphisms in the multidrug resistance 1 gene (MDR1) on hepatocellular carcinoma (HCC) susceptibility through association analysis. A total of 632 HCC patients and 645 cancer-free controls were enrolled in this study. The c.1564A>T genetic polymorphisms were genotyped by created restriction ... more

Y.Y. Wan; X.W. Wang; H.X. Hui; L. Wan
05/16/2014
Clinical outcome; Hepatocellular carcinoma; Polymorphism; susceptibility; XPD; XRCC1

We explored the association between 4 XRCC1 (Arg194Trp and Arg399Gln) and XPD (Asp312Asn and Lys751Gln) polymorphisms with the development and prognosis of hepatocellular carcinoma (HCC). A total of 218 cases with HCC and 277 healthy controls were included in the study. Genotyping of the XRCC1 (Arg194Trp and Arg399Gln) and XPD (Asp312Asn and Lys751Gln) polymorphisms was ... more

J.S. Wu; Y.P. Chen; L.C. Wang; Y.J. Yang; C.W. Deng; B.X. Hou; Z.L. He; J.X. Chen
01/10/2014
Hepatocellular carcinoma; Molecular marker; Single nucleotide polymorphism; susceptibility; XRCC1 gene

The human X-ray repair cross-complementing protein 1 (XRCC1) gene is a potentially gene determining hepatocellular carcinoma (HCC) susceptibility. The purpose of this study was to evaluate the association between XRCC1 and susceptibility to HCC. The association of XRCC1 polymorphisms with HCC susceptibility was investigated in 460 HCC patients and 463 controls ... more

X.F. Li; Y.X. Chen; W.W. Ye; X.F. Tao; J.H. Zhu; S. Wu; L.Q. Lou
05/18/2015
Cyclin D1 G870A; Hepatocellular carcinoma; Leukemia; Polymorphism; susceptibility

Cyclin D1 (CCND1) is a key protein involved in cell-cycle regulation, and the CCND1 G870A polymorphism is associated with many types of malignancy. Studies examining the associations between this G870A polymorphism and susceptibility to leukemia and hepatocellular carcinoma (HCC) have shown inconsistent results. Therefore, we conducted a meta-analysis to clarify these ... more

Y. Zhao; H.R. He; M.Y. Wang; X.D. Ren; L. Zhang; Y.L. Dong; J. Lu
01/04/2013
Hepatocellular carcinoma; MIF-794CATT; Polymorphism; Promoter

Hepatocellular carcinoma (HCC) is one of the most common worldwide malignancies. A relative complete diagnosis system for primary carcinoma of liver has already been established, but the surgical prognosis for HCC, which depends mainly on postoperative pathological classification and data of recurrence and metastasis, lacks valid experimental indicators. Macrophage migration inhibition ... more

T. Yuan; C. Tang; M. Chen; S. Deng; P. Chen
11/18/2013
Gene expression; Hepatocellular carcinoma; Laser capture microdissection; Microarray

The aim of this study was to identify genomic aberrations in hepatocellular carcinoma (HCC) by using laser capture microdissection (LCM) combined with microarray analysis. Samples were procured by LCM from HCC and patient-matched normal liver tissue surgically resected from 4 patients. RNA was isolated from the samples and reverse transcribed into cDNA. After 2-cycle linear amplification and 2 ... more

Y.M. Wei; Y.Y. Li; Y.C. Zhang; Y.Q. Nie
09/13/2013
Apoptosis; Hepatocellular carcinoma; Methylation regulation; MicroRNA-122

The regulation mechanism and significance of microRNA-122 (miRNA-122) expression are unclear. The aim of this study was to investigate the effects of DNA methylation on liver-specific miRNA-122 expression, cell proliferation, and apoptosis in hepatocellular carcinoma. Methylation of the miRNA-122 promoter region was detected through methylation sequencing. The level of miRNA-122 ... more

T.J. Xing; H.T. Xu; W.Q. Yu; D.F. Jiang
09/19/2013
Gene polymorphism; Hepatocellular carcinoma; Interleukin-28B; Liver cirrhosis; Meta-analysis; rs12979860

We examined the association of the interleukin-28B (IL-28B) gene rs12979860 T/C polymorphism with development of hepatitis virus-related hepatocellular carcinoma (HCC) and liver cirrhosis (LC). Two investigators independently searched the PubMed, Elsevier, EMBASE, Web of Science, Wiley Online Library, and Chinese National Knowledge Infrastructure data bases. Pooled odds ratios (ORs) and ... more

G.J. Suo; Z.X. Zhao
06/13/2013
Gene polymorphism; Hepatocellular carcinoma; Meta-analysis; XRCC1

XRCC1-399 allele polymorphisms have been reported to be associated with susceptibility to hepatocellular carcinoma (HCC), but the conclusions of the various studies have been inconsistent. We conducted a meta-analysis of available studies to determine whether XRCC1-399 alleles influence susceptibility to hepatocellular carcinoma. We searched English-language databases, ... more

X.Y. Zeng; J.M. Huang; J.W. Xu; Y. Xu; H.P. Yu; L. Ji; X.Q. Qiu
04/25/2013
Hepatitis B; Hepatocellular carcinoma; Histocompatibility antigen

Hepatocellular carcinoma is an infection of variable incidence that can be caused by hepatitis B virus (HBV), which is endemic in the Amazon region. The diagnosis of HBV can be performed through the use of serum markers such as the hepatitis B surface antigen. The chronic HBV can cause mutagenesis and carcinogenesis, being the susceptibility of infection due to allele human leukocyte ... more

S.R.S. Chalub; R.M. da Silva; A.P.S. da Silva; P.F. de Aquino; A. Sadahiro; A.N. Kalil

Pages